Title: Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827
Authors: Bringas, CF
Ahangar, MS
Cuenco, J
Liu, HL
Addinsall, AB
Lindahl, M
Ovens, AJ
Febbraio, MA
Foretz, M
Scott, JW
Zeqiraj, E
Sakamoto, K
Issue Year: 2025
Publisher AMER ASSOC ADVANCEMENT SCIENCE
Series SCIENCE ADVANCES:
Abstract Inhibition of adenosine 5 '-monophosphate (AMP)-activated protein kinase (AMPK) is under increasing investigation for its therapeutic potential in many diseases. Existing AMPK inhibitors are however limited, with poor selectivity and substantial off-target effects. Here, we provide mechanistic insights and describe the cellular selectivity of the recently identified AMPK inhibitor BAY-3827. A 2.5-angstrom cocrystal structure of the AMPK kinase domain with BAY-3827 revealed distinct features including a disulfide bridge between the alpha D helix Cys(106) and the activation loop residue Cys(174). This bridge appears to stabilize the activation loop such that Asn(162) repositions the Asp-Phe-Gly (DFG) motif Phe(158) toward the C-terminal lobe, displacing His(137) and disrupting the regulatory spine, promoting an inactive kinase state. In hepatocytes, BAY-3827 blocked AMPK activator (MK-8722)-mediated phosphorylation of ACC1 and corresponding inhibition of lipogenesis. Transcriptome analysis revealed that BAY-3827 down-regulated similar to 30% of MK-8722-stimulated AMPK-dependent genes. We establish the molecular and cellular basis of BAY-3827's selectivity and utility for delineating AMPK functions while highlighting its limitations.
URI: https://publications.svi.edu.au/publications/10297
Other Identifiers 10.1126/sciadv.adx2434
Publication type Article